Advertisement

Lymphangiosis carcinomatosa: unabhängiger Prognosefaktor bei Patienten mit Plattenepithelcarcinom des Oesophagus

  • B. L. D. M. Brücher
  • H. J. Stein
  • M. Werner
  • J. R. Siewert
Part of the Deutsche Gesellschaft für Chirurgie book series (DTGESCHIR, volume 31)

Abstract

Background: The objective of this study was to clarify the presence and prognostic impact of LVI in a large number of patients resected for esophageal squamous cell carcinoma (SCC) at one surgical center. Methods: Therefore, 366 patients, which had a primary resection for SCC, were analysed by uni- and multivariate analysis. Follow-up is complete for 93.7% patients with a median follow-up of 8.3 years. Results: The total rate of LVI was 39.1% (n = 143). Univariate analysis revealed a significant relationship between LVI and different T-categories (p = 0.001), N-categories (p < 0.0001), M-categories (p < 0.0001), UICC-stages (p < 0.0001) and residual tumor (p < 0.0001). Multivariate analysis of the R0-resected patients proved LVI as an independent prognostic factor. The 2-, 5- and 10-year-survival-rates in patients with LVI were 28.5%, 11.1% and 9.2% compared to 63.4%, 46.6% and 27% without LVI (p < 0.0001). Patients with LVI had a median-survival-time of 11.4 months compared to 28.6 months without LVI (p < 0.0001). R0-resected patients without LVI had a median-survival-time of 54.1 months compared to 12.1 months in patients with LVI (p < 0.0001) and compared to 11.3 months in R1-resected patients (p < 0.0001). Conclusions: These data clearly show, that LVI is an independent prognostic factor in patients with SCC and confirm the importance of a systematic histopathological workup. The prognosis of R0-resected patients with LVI is equal to patients with an incomplete tumor resection. This supports the inclusion of LVI in the UlCC-classification system for esophageal carcinoma.

Literatur

  1. 1.
    Siewert JR, Brücher BLDM, Stein HJ, Fink U (1998) [Esophagus carcinoma - systemic or local risk of recurrence - which perioperative measures are successful?]. Langenbecks Arch Chir Suppl Kongressbd 115: 290–294PubMedGoogle Scholar
  2. 2.
    Sobin LH, Wittekind C. [TNM classification of malignant tumors. 5th edition]. Wiley-Liss 1997Google Scholar
  3. 3.
    Tang R, Wang JY, Tsao KC, Ho YS (1999) Lymphangiosis as a predictor of outcome in patients with primary diffusely infiltrative adenocarcinoma of the colon and rectum. Arch Surg 134: 157– 160PubMedCrossRefGoogle Scholar
  4. 4.
    Nakahara H, Ishikawa T, Itabashi M, Hirota T (1992) Diffusely infiltrating primary colorectal carcinoma of linitis plastica and lymphangiosis types. Cancer 69: 901 -906PubMedCrossRefGoogle Scholar
  5. 5.
    Sarbia M, Bittinger F, Porschen R, Dutkowski P, Willers R, Gabbert HE (1996) Tumor vascularization and prognosis in squamous cell carcinomas of the esophagus. Anticancer Res 16: 2117–2121PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2002

Authors and Affiliations

  • B. L. D. M. Brücher
    • 1
    • 3
  • H. J. Stein
    • 1
  • M. Werner
    • 2
  • J. R. Siewert
    • 1
  1. 1.Chirurgische Klinik und PoliklinikGermany
  2. 2.Institut für Allgemeine Pathologie und Pathologische Anatomie, Klinikum rechts der IsarTechnische UniversitätMünchenGermany
  3. 3.Chirurgische Klinik und Poliklinik, Klinikum rechts der IsarTechnische Universität MünchenMünchenGermany

Personalised recommendations